Myelodysplastic Syndrome (MDS)
What is Myelodysplastic syndrome (MDS)?
Myelodysplastic syndrome, often called MDS, is a group of blood disorders that affect your bone marrow. Your bone marrow is the spongy tissue inside your bones that makes blood cells. In MDS, the bone marrow produces blood cells that are abnormally shaped or do not work properly. These dysplastic cells often die before leaving the bone marrow or soon after entering your bloodstream.
When your body cannot make enough healthy blood cells, you may develop low counts of red blood cells, white blood cells, or platelets. This leads to symptoms like fatigue, infections, and easy bleeding. MDS ranges from mild to severe. Some forms progress slowly over years, while others advance more quickly. In about 30 percent of cases, MDS can transform into acute myeloid leukemia, a fast-growing blood cancer.
MDS is more common in people over age 60, though it can occur at any age. Early detection through blood testing allows for better monitoring and treatment planning. Understanding your blood cell counts helps you and your doctor track disease progression and make informed decisions about your care.
Symptoms
- Persistent fatigue and weakness that does not improve with rest
- Shortness of breath during normal activities
- Pale skin or paleness of the lips and nail beds
- Frequent infections or infections that do not clear up quickly
- Easy bruising or small red spots under the skin
- Unusual bleeding, including nosebleeds or bleeding gums
- Dizziness or lightheadedness
- Rapid or irregular heartbeat
- Loss of appetite or unexplained weight loss
Many people with early MDS have no symptoms at all. The condition is often discovered during routine blood work done for other reasons. As MDS progresses, symptoms typically become more noticeable as blood cell counts drop lower.
Concerned about Myelodysplastic syndrome (MDS)? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
MDS develops when something damages the DNA of bone marrow cells. This damage causes the cells to grow and divide abnormally. Most cases of MDS have no known cause and are called primary or de novo MDS. The risk increases significantly with age, with most cases occurring in people over 60. Men develop MDS slightly more often than women. Some people have genetic mutations that increase their risk of developing blood disorders like MDS.
Secondary MDS can occur after exposure to certain cancer treatments, including chemotherapy and radiation therapy. Benzene and other toxic chemicals also increase MDS risk. People who work in industries with chemical exposure face higher risk. Smoking is another risk factor that damages bone marrow over time. Some rare inherited conditions, such as Fanconi anemia, also increase the likelihood of developing MDS. Previous blood disorders or aplastic anemia may progress to MDS in some cases.
How it's diagnosed
MDS is diagnosed through a combination of blood tests and bone marrow examination. Blood work typically shows low counts in one or more types of blood cells. Your red blood cell count, or RBC, is particularly important for diagnosis and monitoring. A low RBC count reflects ineffective production of red blood cells from dysplastic bone marrow. Regular blood testing helps track disease progression and response to treatment over time.
Rite Aid offers blood testing that includes red blood cell count measurement, an essential marker for monitoring MDS. Your doctor will also order a bone marrow biopsy to examine the cells directly under a microscope. This test looks for abnormal cell shapes and chromosome changes. Genetic testing of bone marrow cells identifies specific mutations that help predict disease behavior. Together, these tests determine your MDS subtype and risk category, which guides treatment decisions.
Treatment options
- Regular blood testing to monitor blood cell counts and disease progression
- Blood transfusions to treat severe anemia and improve energy levels
- Growth factor injections that stimulate the bone marrow to produce more blood cells
- Medications like azacitidine or decitabine that help bone marrow cells mature properly
- Lenalidomide for specific MDS subtypes with chromosome deletions
- Immunosuppressive therapy for certain lower-risk MDS cases
- Stem cell transplant, the only potential cure, for eligible patients
- Supportive care with antibiotics to prevent and treat infections
- Iron chelation therapy if frequent transfusions cause iron overload
- Eating a nutrient-dense diet with adequate protein, iron, and B vitamins
- Avoiding smoking and limiting alcohol to reduce further bone marrow stress
- Managing stress through gentle exercise, adequate sleep, and relaxation techniques
Concerned about Myelodysplastic syndrome (MDS)? Get tested at Rite Aid.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
MDS is a bone marrow disorder where blood cells develop abnormally but still mature to some degree. Leukemia involves immature blast cells that multiply rapidly and never mature properly. About 30 percent of MDS cases eventually transform into acute myeloid leukemia. Both conditions affect blood cell production, but they require different treatment approaches.
Stem cell transplant is currently the only treatment that can cure MDS. However, only some patients are eligible for this procedure due to age, overall health, and disease characteristics. For many people, treatment focuses on managing symptoms, improving quality of life, and slowing disease progression. New medications continue to improve outcomes for patients who cannot have a transplant.
MDS progression varies widely depending on the subtype and risk category. Lower-risk MDS may remain stable for many years with minimal symptoms. Higher-risk MDS can progress more rapidly, sometimes advancing to acute leukemia within months. Regular blood testing helps doctors monitor the pace of progression and adjust treatment accordingly.
A complete blood count, or CBC, is the primary screening test for MDS. It measures your red blood cell count, white blood cell count, and platelet count. Low counts in one or more cell types may indicate MDS or another blood disorder. Your doctor will also look at blood cell shape and size under a microscope to identify abnormal characteristics typical of MDS.
Most cases of MDS are not inherited and occur randomly in people with no family history. However, certain rare inherited conditions increase MDS risk, including Fanconi anemia and other bone marrow failure syndromes. Some genetic mutations can be passed down in families. If you have relatives with MDS or other blood disorders, discuss genetic counseling with your doctor.
Life expectancy with MDS varies greatly based on disease subtype, risk category, age, and overall health. Lower-risk MDS patients may live many years with good quality of life. Higher-risk MDS has a shorter average survival time, often measured in months to a few years. Your doctor uses classification systems to predict prognosis and guide treatment decisions based on your specific situation.
While lifestyle changes cannot cure MDS, they support overall health and treatment effectiveness. Eating a balanced diet rich in protein and nutrients helps your body manage low blood counts. Avoiding infections through good hygiene and avoiding sick contacts protects you when white blood cells are low. Quitting smoking and limiting alcohol reduce additional stress on your bone marrow.
Blood testing frequency depends on your MDS subtype, risk category, and current treatment. Many patients need blood work every few weeks to monitor cell counts and disease activity. If you receive blood transfusions, testing may occur before each transfusion. Regular monitoring helps your care team detect changes early and adjust your treatment plan as needed.
Fatigue in MDS results primarily from anemia, which means you have too few red blood cells. Red blood cells carry oxygen throughout your body. When counts drop, your organs and muscles do not get enough oxygen, causing weakness and tiredness. Blood transfusions or medications that stimulate red blood cell production can improve energy levels significantly.
Yes, MDS should be managed by a hematologist who specializes in blood disorders. These specialists have expertise in diagnosing MDS subtypes, predicting disease behavior, and selecting appropriate treatments. They stay current on new medications and clinical trials. Your primary care doctor can coordinate with your hematologist to provide overall care and manage other health conditions.